Loading…

A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics

Purpose. During corneal infection, cytotoxic Pseudomonas aeruginosa strains remain mostly extracellular, while invasive strains can enter corneal cells and replicate within them. We tested the hypothesis that ofloxacin, which easily penetrates host cell membranes, would be more effective than the le...

Full description

Saved in:
Bibliographic Details
Published in:Current eye research 2003-11, Vol.27 (5), p.289-299
Main Authors: Lee, Ellen J., Truong, Tan N., Mendoza, Myra N., Fleiszig, Suzanne M.J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313
cites cdi_FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313
container_end_page 299
container_issue 5
container_start_page 289
container_title Current eye research
container_volume 27
creator Lee, Ellen J.
Truong, Tan N.
Mendoza, Myra N.
Fleiszig, Suzanne M.J.
description Purpose. During corneal infection, cytotoxic Pseudomonas aeruginosa strains remain mostly extracellular, while invasive strains can enter corneal cells and replicate within them. We tested the hypothesis that ofloxacin, which easily penetrates host cell membranes, would be more effective than the less cell-permeable antibiotic tobramycin, for treatment of corneal infection by an invasive P. aeruginosa strain. Methods. A murine model of P. aeruginosa keratitis was used to compare the response to ofloxacin, tobramycin, prednisolone acetate, and non-preserved saline treatment, as well as combination antibiotic-corticosteroid therapy for infection caused by a cytotoxic strain (6206) and an invasive strain (PAO1). Treatment involved hourly eye drop administration for 12 hours. Results. As expected, tobramycin was less effective at eradicating viable bacteria from corneas infected with the invasive strain. Despite rapid sterilization of corneas in other antibiotic treated groups, disease progression occurred during the 12 hour treatment period. Both antibiotics hastened disease resolution over the next 7 days for infections caused by either strain. Corticosteroid use during the 12 hour treatment period was of little added benefit. Conclusions. Differences between invasive and cytotoxic strain infections in their early response to the different therapeutic regimens did not translate to notable differences after 7 days, but the effects of antibiotics in halting disease progression were delayed for both strain types. These results suggest that successful management might be improved by addressing factors contributing to disease progression during sterilization of the cornea by antibiotics.
doi_str_mv 10.1076/ceyr.27.5.289.17220
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_14562165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71278694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi1ERZfCL0BCPnFLsB3HTg4gVRVfUqVyaM_WrGOzrhI7eJyF_fdk2ZUQl55mNHrmndFDyBvOas60em_dIddC120tur7mWgj2jGy4VKxaW_GcbJjQvGpU11ySl4iPjB0H8gW55LJVgqt2Q_bX1KZphhwwRZo8DXEPGPaOQhyoPZRU0u9g6Xd0y5CmFAEpuLz8CDEhUCwZQqxCHBbrVj7l6GCkQ0AH6Gh2OKeIDmlJtOxchtktJVh8RS48jOhen-sVefj86f7ma3V79-XbzfVtZaVWpQLfbjl0qtNeKsm8ZZ4LyXvFGfi-Y14zKztlwTLZbEHYoekbMWxBKi5Ew5sr8u6UO-f0c3FYzBTQunGE6NKCRnOhO9XLFWxOoM0JMTtv5hwmyAfDmTnqNkfdRmjTmlW3-at73Xp7jl-2kxv-7Zz9rsDHExCiT3mCXymPgylwGFP2GaINaJqnL3z4L2C36i07C9mZx7TkuMp78sM_jHuorQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71278694</pqid></control><display><type>article</type><title>A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Lee, Ellen J. ; Truong, Tan N. ; Mendoza, Myra N. ; Fleiszig, Suzanne M.J.</creator><creatorcontrib>Lee, Ellen J. ; Truong, Tan N. ; Mendoza, Myra N. ; Fleiszig, Suzanne M.J.</creatorcontrib><description>Purpose. During corneal infection, cytotoxic Pseudomonas aeruginosa strains remain mostly extracellular, while invasive strains can enter corneal cells and replicate within them. We tested the hypothesis that ofloxacin, which easily penetrates host cell membranes, would be more effective than the less cell-permeable antibiotic tobramycin, for treatment of corneal infection by an invasive P. aeruginosa strain. Methods. A murine model of P. aeruginosa keratitis was used to compare the response to ofloxacin, tobramycin, prednisolone acetate, and non-preserved saline treatment, as well as combination antibiotic-corticosteroid therapy for infection caused by a cytotoxic strain (6206) and an invasive strain (PAO1). Treatment involved hourly eye drop administration for 12 hours. Results. As expected, tobramycin was less effective at eradicating viable bacteria from corneas infected with the invasive strain. Despite rapid sterilization of corneas in other antibiotic treated groups, disease progression occurred during the 12 hour treatment period. Both antibiotics hastened disease resolution over the next 7 days for infections caused by either strain. Corticosteroid use during the 12 hour treatment period was of little added benefit. Conclusions. Differences between invasive and cytotoxic strain infections in their early response to the different therapeutic regimens did not translate to notable differences after 7 days, but the effects of antibiotics in halting disease progression were delayed for both strain types. These results suggest that successful management might be improved by addressing factors contributing to disease progression during sterilization of the cornea by antibiotics.</description><identifier>ISSN: 0271-3683</identifier><identifier>EISSN: 1460-2202</identifier><identifier>DOI: 10.1076/ceyr.27.5.289.17220</identifier><identifier>PMID: 14562165</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Administration, Topical ; Animals ; Anti-Bacterial Agents - therapeutic use ; Cornea - microbiology ; Corneal Ulcer - drug therapy ; Corneal Ulcer - microbiology ; Disease Models, Animal ; Drug Therapy, Combination ; Eye Infections, Bacterial - drug therapy ; Eye Infections, Bacterial - microbiology ; Female ; Glucocorticoids - therapeutic use ; Mice ; Mice, Inbred C57BL ; Ofloxacin - therapeutic use ; Prednisolone - analogs &amp; derivatives ; Prednisolone - therapeutic use ; Pseudomonas aeruginosa - isolation &amp; purification ; Pseudomonas aeruginosa - pathogenicity ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Tobramycin - therapeutic use</subject><ispartof>Current eye research, 2003-11, Vol.27 (5), p.289-299</ispartof><rights>2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313</citedby><cites>FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14562165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Ellen J.</creatorcontrib><creatorcontrib>Truong, Tan N.</creatorcontrib><creatorcontrib>Mendoza, Myra N.</creatorcontrib><creatorcontrib>Fleiszig, Suzanne M.J.</creatorcontrib><title>A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics</title><title>Current eye research</title><addtitle>Curr Eye Res</addtitle><description>Purpose. During corneal infection, cytotoxic Pseudomonas aeruginosa strains remain mostly extracellular, while invasive strains can enter corneal cells and replicate within them. We tested the hypothesis that ofloxacin, which easily penetrates host cell membranes, would be more effective than the less cell-permeable antibiotic tobramycin, for treatment of corneal infection by an invasive P. aeruginosa strain. Methods. A murine model of P. aeruginosa keratitis was used to compare the response to ofloxacin, tobramycin, prednisolone acetate, and non-preserved saline treatment, as well as combination antibiotic-corticosteroid therapy for infection caused by a cytotoxic strain (6206) and an invasive strain (PAO1). Treatment involved hourly eye drop administration for 12 hours. Results. As expected, tobramycin was less effective at eradicating viable bacteria from corneas infected with the invasive strain. Despite rapid sterilization of corneas in other antibiotic treated groups, disease progression occurred during the 12 hour treatment period. Both antibiotics hastened disease resolution over the next 7 days for infections caused by either strain. Corticosteroid use during the 12 hour treatment period was of little added benefit. Conclusions. Differences between invasive and cytotoxic strain infections in their early response to the different therapeutic regimens did not translate to notable differences after 7 days, but the effects of antibiotics in halting disease progression were delayed for both strain types. These results suggest that successful management might be improved by addressing factors contributing to disease progression during sterilization of the cornea by antibiotics.</description><subject>Administration, Topical</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Cornea - microbiology</subject><subject>Corneal Ulcer - drug therapy</subject><subject>Corneal Ulcer - microbiology</subject><subject>Disease Models, Animal</subject><subject>Drug Therapy, Combination</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Eye Infections, Bacterial - microbiology</subject><subject>Female</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Ofloxacin - therapeutic use</subject><subject>Prednisolone - analogs &amp; derivatives</subject><subject>Prednisolone - therapeutic use</subject><subject>Pseudomonas aeruginosa - isolation &amp; purification</subject><subject>Pseudomonas aeruginosa - pathogenicity</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Tobramycin - therapeutic use</subject><issn>0271-3683</issn><issn>1460-2202</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAQhi1ERZfCL0BCPnFLsB3HTg4gVRVfUqVyaM_WrGOzrhI7eJyF_fdk2ZUQl55mNHrmndFDyBvOas60em_dIddC120tur7mWgj2jGy4VKxaW_GcbJjQvGpU11ySl4iPjB0H8gW55LJVgqt2Q_bX1KZphhwwRZo8DXEPGPaOQhyoPZRU0u9g6Xd0y5CmFAEpuLz8CDEhUCwZQqxCHBbrVj7l6GCkQ0AH6Gh2OKeIDmlJtOxchtktJVh8RS48jOhen-sVefj86f7ma3V79-XbzfVtZaVWpQLfbjl0qtNeKsm8ZZ4LyXvFGfi-Y14zKztlwTLZbEHYoekbMWxBKi5Ew5sr8u6UO-f0c3FYzBTQunGE6NKCRnOhO9XLFWxOoM0JMTtv5hwmyAfDmTnqNkfdRmjTmlW3-at73Xp7jl-2kxv-7Zz9rsDHExCiT3mCXymPgylwGFP2GaINaJqnL3z4L2C36i07C9mZx7TkuMp78sM_jHuorQ</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Lee, Ellen J.</creator><creator>Truong, Tan N.</creator><creator>Mendoza, Myra N.</creator><creator>Fleiszig, Suzanne M.J.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031101</creationdate><title>A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics</title><author>Lee, Ellen J. ; Truong, Tan N. ; Mendoza, Myra N. ; Fleiszig, Suzanne M.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Administration, Topical</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Cornea - microbiology</topic><topic>Corneal Ulcer - drug therapy</topic><topic>Corneal Ulcer - microbiology</topic><topic>Disease Models, Animal</topic><topic>Drug Therapy, Combination</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Eye Infections, Bacterial - microbiology</topic><topic>Female</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Ofloxacin - therapeutic use</topic><topic>Prednisolone - analogs &amp; derivatives</topic><topic>Prednisolone - therapeutic use</topic><topic>Pseudomonas aeruginosa - isolation &amp; purification</topic><topic>Pseudomonas aeruginosa - pathogenicity</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Tobramycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Ellen J.</creatorcontrib><creatorcontrib>Truong, Tan N.</creatorcontrib><creatorcontrib>Mendoza, Myra N.</creatorcontrib><creatorcontrib>Fleiszig, Suzanne M.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Ellen J.</au><au>Truong, Tan N.</au><au>Mendoza, Myra N.</au><au>Fleiszig, Suzanne M.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics</atitle><jtitle>Current eye research</jtitle><addtitle>Curr Eye Res</addtitle><date>2003-11-01</date><risdate>2003</risdate><volume>27</volume><issue>5</issue><spage>289</spage><epage>299</epage><pages>289-299</pages><issn>0271-3683</issn><eissn>1460-2202</eissn><abstract>Purpose. During corneal infection, cytotoxic Pseudomonas aeruginosa strains remain mostly extracellular, while invasive strains can enter corneal cells and replicate within them. We tested the hypothesis that ofloxacin, which easily penetrates host cell membranes, would be more effective than the less cell-permeable antibiotic tobramycin, for treatment of corneal infection by an invasive P. aeruginosa strain. Methods. A murine model of P. aeruginosa keratitis was used to compare the response to ofloxacin, tobramycin, prednisolone acetate, and non-preserved saline treatment, as well as combination antibiotic-corticosteroid therapy for infection caused by a cytotoxic strain (6206) and an invasive strain (PAO1). Treatment involved hourly eye drop administration for 12 hours. Results. As expected, tobramycin was less effective at eradicating viable bacteria from corneas infected with the invasive strain. Despite rapid sterilization of corneas in other antibiotic treated groups, disease progression occurred during the 12 hour treatment period. Both antibiotics hastened disease resolution over the next 7 days for infections caused by either strain. Corticosteroid use during the 12 hour treatment period was of little added benefit. Conclusions. Differences between invasive and cytotoxic strain infections in their early response to the different therapeutic regimens did not translate to notable differences after 7 days, but the effects of antibiotics in halting disease progression were delayed for both strain types. These results suggest that successful management might be improved by addressing factors contributing to disease progression during sterilization of the cornea by antibiotics.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>14562165</pmid><doi>10.1076/ceyr.27.5.289.17220</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0271-3683
ispartof Current eye research, 2003-11, Vol.27 (5), p.289-299
issn 0271-3683
1460-2202
language eng
recordid cdi_pubmed_primary_14562165
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Administration, Topical
Animals
Anti-Bacterial Agents - therapeutic use
Cornea - microbiology
Corneal Ulcer - drug therapy
Corneal Ulcer - microbiology
Disease Models, Animal
Drug Therapy, Combination
Eye Infections, Bacterial - drug therapy
Eye Infections, Bacterial - microbiology
Female
Glucocorticoids - therapeutic use
Mice
Mice, Inbred C57BL
Ofloxacin - therapeutic use
Prednisolone - analogs & derivatives
Prednisolone - therapeutic use
Pseudomonas aeruginosa - isolation & purification
Pseudomonas aeruginosa - pathogenicity
Pseudomonas Infections - drug therapy
Pseudomonas Infections - microbiology
Tobramycin - therapeutic use
title A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20invasive%20and%20cytotoxic%20Pseudomonas%20aeruginosa%20strain-induced%20corneal%20disease%20responses%20to%20therapeutics&rft.jtitle=Current%20eye%20research&rft.au=Lee,%20Ellen%20J.&rft.date=2003-11-01&rft.volume=27&rft.issue=5&rft.spage=289&rft.epage=299&rft.pages=289-299&rft.issn=0271-3683&rft.eissn=1460-2202&rft_id=info:doi/10.1076/ceyr.27.5.289.17220&rft_dat=%3Cproquest_pubme%3E71278694%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c476t-af5b1a8687f4640fc0f12419610af980f70c486cac043ba2cd3932dba46122313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71278694&rft_id=info:pmid/14562165&rfr_iscdi=true